USP19 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.781700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.423170E-01
Normal-vs-Stage2
4.460100E-02
Normal-vs-Stage3
4.776700E-03
Normal-vs-Stage4
3.954600E-01
Stage1-vs-Stage2
7.003600E-01
Stage1-vs-Stage3
1.199940E-02
Stage1-vs-Stage4
3.948800E-01
Stage2-vs-Stage3
5.983400E-03
Stage2-vs-Stage4
2.180800E-01
Stage3-vs-Stage4
3.318700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.351800E-02
Normal-vs-AfricanAmerican
5.810100E-02
Normal-vs-Asian
1.198640E-01
Caucasian-vs-AfricanAmerican
9.078600E-01
Caucasian-vs-Asian
8.635000E-01
AfricanAmerican-vs-Asian
8.302800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.289700E-02
Normal-vs-Female
3.961800E-02
Male-vs-Female
6.199000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.798600E-01
Normal-vs-Age(41-60Yrs)
5.272100E-02
Normal-vs-Age(61-80Yrs)
5.565600E-02
Normal-vs-Age(81-100Yrs)
3.691900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.304600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.312000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.581200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.545600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.282600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.442800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.853700E-02
Normal-vs-Daily Drinker
4.456300E-02
Normal-vs-Weekly Drinker
1.070590E-01
Normal-vs-Occasional Drinker
1.154840E-01
Normal-vs-Social Drinker
5.678500E-02
Non Drinker-vs-Daily Drinker
4.902000E-01
Non Drinker-vs-Weekly Drinker
2.647400E-01
Non Drinker-vs-Occasional Drinker
1.359390E-01
Non Drinker-vs-Social Drinker
1.900160E-01
Daily Drinker-vs-Weekly Drinker
5.914400E-01
Daily Drinker-vs-Occasional Drinker
3.929800E-01
Daily Drinker-vs-Social Drinker
4.855600E-01
Weekly Drinker-vs-Occasional Drinker
8.111000E-01
Weekly Drinker-vs-Social Drinker
9.262200E-01
Occasional Drinker-vs-Social Drinker
8.657600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.081600E-01
Normal-vs-Grade 2
5.848600E-01
Normal-vs-Grade 3
5.540400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.619400E-01
Grade 1-vs-Grade 3
4.999400E-01
Grade 1-vs-Grade 4
2.081600E-01
Grade 2-vs-Grade 3
4.066000E-01
Grade 2-vs-Grade 4
5.848600E-01
Grade 3-vs-Grade 4
5.540400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.279600E-02
Normal-vs-NonDiabetic
3.760100E-02
Diabetic-vs-NonDiabetic
8.040000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.336790E-01
Normal-vs-NoPancreatitis
4.375700E-02
Pancreatitis-vs-NoPancreatitis
7.833600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.868000E-02
Normal-vs-N1
3.951800E-02
N0-vs-N1
5.558200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.985500E-02
Normal-vs-TP53-NonMutant
1.978190E-01
TP53-Mutant-vs-TP53-NonMutant
8.989600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
